Navigation Links
Advances in mollusk parasite culturing methods drives research
Date:7/8/2014

Researchers at Bigelow Laboratory for Ocean Sciences dug into the last 70 years of peer-reviewed publications about protozoan parasites that infest bivalve mollusks and found that when an organism can be cultured in the laboratory, more papers and greater understanding result. Senior Research Scientists, Jos Fernndez Robledo and Nicholas Record co-authored an analysis of peer-reviewed publications since 1950 and reported their findings in the June 23 edition of PLOS ONE, an open access journal covering broad aspects of basic and applied biology.

Fernndez-Robledo and Record partnered with Dr. Gerardo R. Vasta of the Institute of Marine and Environmental Technology of the University of Maryland, Baltimore to identify potential milestone discoveries or achievements in the field that may have driven the intensity of the research in subsequent years and significantly increased publication rates by 3-10 fold and promoted investigations into the basic biology of the parasites. 1950 was chosen as the starting date because it was the first year a description of protozoan parasite Perkinsus marinus was recorded and associated with a mass mortality of eastern oysters in the Gulf coast region. Perkinsus is one of four major protozoan parasite genus included in the study. The others are Haplosporidium, Marteilia, and Bonamia.

"These parasites are globally recognized as major threats to natural and farmed bivalve populations, " explains Fernndez-Robledo. "The more we learn about how they function, interact, and evolve, the greater the likelihood that we can figure out how to control their spread in important food resources. Over the past 70 years, we've tripled what is known about mollusk parasites by successfully culturing and conducting experiments on the laboratory bench." Bigelow Laboratory for Ocean Sciences has cultured parasitic hosts in its East Boothbay facility and is leading research on parasites that infect bivalve mollusks.

Certain parasite species such as Perkinsus marinus, Perkinsus olseni, Marteilia refringens, Bonamia ostreae and Bonamia exitiosa infect abalones, clams, mussels, oyster, and scallops around the world and cause mass mortalities that are especially devastating for aquacultures and commercial harvesting.

The researchers systematically analyzed the literature and found that advances in parasite purification and culture methodologies positively increased publication rates, which often resulted in new molecular tools and resources. Cultures have accelerated screening for drugs effective against specific parasites, and identified mechanisms that parasites use to enter, survive, multiply, and, eventually, kill oysters. Because of what has been learned, scientists are now able to characterize parasite strains from different locations in the United States, helping to define under what circumstances a strain may become virulent and to identify oyster strains that can be resistant to resident parasites.

This study is the first to provide a side-by-side comparison of the publication records for the four main genera of protozoan parasites affecting mollusks. Its conclusions may be used as tool to help researchers fine-tune their research projects to gain continued funding, for students entering the field to narrow their research focus, and for state and local agencies to prioritize research efforts and funds It also shows that early efforts supporting the development of cultures methodologies (basic science) results in a large body of knowledge toward new intervention strategies against disease (applied science).


'/>"/>

Contact: Darlene Crist
dtcrist@bigelow.org
207-315-2567 x103
Bigelow Laboratory for Ocean Sciences
Source:Eurekalert

Related medicine news :

1. Zebrafish research meeting to highlight advances in genetics and developmental biology
2. Advances in predictive hypoglycemia-minimizing technology from Animas-JDRF collaboration
3. BioAnalytix advances the biologic drug development
4. Major advances in breast, prostate, colorectal cancer featured at ASCO Annual Meeting
5. EuroPCR 2014 showcases technological advances in complex cardiovascular interventions
6. Molecule linked to aggressive pancreatic cancer offers potential clinical advances
7. Space-tested fluid flow concept advances infectious disease diagnoses
8. Smartphone app reads blood oxygen levels to hospital standards, advances to global obstetrics tests
9. Autism Speaks study finds advances towards universal early screening
10. WesternU Team Advances Understanding of Mechanisms of Learning and Neural Degeneration
11. New Advances in Oral Technology from Henning Family Dental in Spokane Create Comfort for Anxious Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... The ... candidates for the Board of Commissioners. Individuals interested in volunteer board service are ... diversity of clinical practice settings and across allied health to contribute to its ...
(Date:2/11/2016)... SURPRISE, ARIZ. (PRWEB) , ... February 11, 2016 , ... ... kids,” a group of men, 60 and older, who gather once a year to ... , Besides a love for the game, the more than 50 players who competed ...
(Date:2/11/2016)... ... February 11, 2016 , ... AccuVein Inc. ... Infusion Therapy Standards of Practice, to include vascular visualization as a standard practice. ... 85% share of the market, facilitates adherence to this standard with its easy ...
(Date:2/11/2016)... ... February 11, 2016 , ... Dickinson Insurance & Financial Services ... a new fundraiser in support of a local boy named Barrett, who has been ... bring awareness to, and rally support for, all local families dealing with childhood cancer. ...
(Date:2/11/2016)... ... ... Be Well Medical Group (Be Well) is pleased to announce the ... Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group is a concierge practice ... their homes, offices or at the practices’ local office. It is also one of ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 11, 2016 ... of the "Molecular Diagnostics Reports Bundle" ... http://www.researchandmarkets.com/research/rp4pg8/molecular ) has announced the addition ... report to their offering. --> ... has announced the addition of the ...
(Date:2/10/2016)... REDWOOD CITY, Calif., Feb. 10, 2016   Genomic Health, Inc. ... progress for the quarter and year ended December 31, 2015. ... in the fourth quarter of 2015, compared with $69.1 million in ... a constant currency basis, revenue increased 9 percent compared with the ... --> U.S. revenue was $63.9 million in the fourth ...
(Date:2/10/2016)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... quarter and full year ended December 31, 2015. ... a transformational year for Vanda with the continued growth ... approval of HETLIOZ for Non-24," said Mihael H. Polymeropoulos, ... to our U.S. product portfolio builds on this success ...
Breaking Medicine Technology: